115 related articles for article (PubMed ID: 16146148)
1. [Avascular necrosis of the jaw bone after bisphosphonate therapy].
Shlomi B; Levy Y; Kleinman S; Better H; Kahn A; Shtabsky A; Chaushu G
Harefuah; 2005 Aug; 144(8):536-9, 600, 599. PubMed ID: 16146148
[TBL] [Abstract][Full Text] [Related]
2. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
Lobato JV; Rodrigues JM; Cavaleiro MV; Lobato JM; Xavier L; Santos JD; Maurício AC
Acta Med Port; 2007; 20(2):185-92. PubMed ID: 17868526
[TBL] [Abstract][Full Text] [Related]
3. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
Friedrich RE; Blake FA
Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
5. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.
Merigo E; Manfredi M; Meleti M; Corradi D; Vescovi P
J Oral Pathol Med; 2005 Nov; 34(10):613-7. PubMed ID: 16202082
[TBL] [Abstract][Full Text] [Related]
6. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates.
Farrugia MC; Summerlin DJ; Krowiak E; Huntley T; Freeman S; Borrowdale R; Tomich C
Laryngoscope; 2006 Jan; 116(1):115-20. PubMed ID: 16481822
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
Grewal VS; Fayans EP
Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
Marx RE; Sawatari Y; Fortin M; Broumand V
J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
[TBL] [Abstract][Full Text] [Related]
9. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
10. Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases.
Vescovi P; Merigo E; Manfredi M; Meleti M; Fornaini C; Bonanini M; Rocca JP; Nammour S
Photomed Laser Surg; 2008 Feb; 26(1):37-46. PubMed ID: 18248160
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
Dimitrakopoulos I; Magopoulos C; Karakasis D
Int J Oral Maxillofac Surg; 2006 Jul; 35(7):588-93. PubMed ID: 16687238
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates and oral cavity avascular bone necrosis: a review of twelve cases.
Salesi N; Pistilli R; Marcelli V; Govoni FA; Bozza F; Bossone G; Venturelli V; Di Cocco B; Pacetti U; Ciorra A; Di Fonso C; Cortesi E; Veltri E; Vecchione A
Anticancer Res; 2006; 26(4B):3111-5. PubMed ID: 16886642
[TBL] [Abstract][Full Text] [Related]
13. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
Alons K; Kuijpers SC; de Jong E; van Merkesteyn JP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb; 107(2):e1-7. PubMed ID: 19071040
[TBL] [Abstract][Full Text] [Related]
14. Osteonecrosis of the jaw associated with bisphosphonate use: Presentation of seven cases and literature review.
Mortensen M; Lawson W; Montazem A
Laryngoscope; 2007 Jan; 117(1):30-4. PubMed ID: 17202926
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate-related osteonecrosis of the jaws (ONJ): a report of two cases.
Pongchaiyakul C; Auraiwan K; Kotruchin P; Kularbkaew C
J Med Assoc Thai; 2007 Nov; 90(11):2494-8. PubMed ID: 18181340
[TBL] [Abstract][Full Text] [Related]
16. Jaw osteonecrosis related to bisphosphonate therapy: a severe secondary disorder.
Dannemann C; Grätz KW; Riener MO; Zwahlen RA
Bone; 2007 Apr; 40(4):828-34. PubMed ID: 17236837
[TBL] [Abstract][Full Text] [Related]
17. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis of the jaw due to bisphosphonates.
Prescrire Int; 2008 Oct; 17(97):202-3. PubMed ID: 19536938
[TBL] [Abstract][Full Text] [Related]
19. Osteonecrosis of the jaws in patients treated with bisphosphonates. Review of the literature and the Milan experience.
Oltolina A; Achilli A; Lodi G; Demarosi F; Sardella A
Minerva Stomatol; 2005; 54(7-8):441-8. PubMed ID: 16211002
[TBL] [Abstract][Full Text] [Related]
20. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.
Estilo CL; Van Poznak CH; Wiliams T; Bohle GC; Lwin PT; Zhou Q; Riedel ER; Carlson DL; Schoder H; Farooki A; Fornier M; Halpern JL; Tunick SJ; Huryn JM
Oncologist; 2008 Aug; 13(8):911-20. PubMed ID: 18695259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
